Researchers hope the advanced warning could enable earlier, less invasive treatments with fewer side effects and better outcomes.

Researchers explore DNA methylation patterns for early ovarian cancer detection, aiming to improve survival rates through ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and ...

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...

Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer. When you purchase through links on our site, we may earn an affiliate ...

Cancer affects millions of people around the world every year. Oftentimes, the signs and symptoms of cancer present themselves once the disease has advanced into its later stages, leaving many wishing ...

In a recent study published in Cancer Cell, researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining ...

In this evaluation of a cfDNA blood-based test, Shield, for the detection of colorectal cancer in an average-risk screening population, sensitivity for colorectal cancer was 83%, and specificity ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...